hCG (Human Chorionic Gonadotropin) Research Evidence
The hCG (Human Chorionic Gonadotropin) evidence base: trials, journals, and what the data does not yet show.
A Six-Decade-Old FDA Label
hCG's FDA approval for hypogonadotropic hypogonadism and fertility use dates back to 1962, one of the oldest, most established hormone therapies in this catalog. In a 2019 study (Madhusoodanan et al., n=20) of men taking hCG as monotherapy, testosterone rose approximately 50%, with roughly half reporting symptom improvement, low libido and erectile dysfunction were each the presenting complaint in 45% of participants.
Regulatory and Legal Status
hCG is prescription-only and FDA-approved, with an exceptionally long track record. It should be obtained through a licensed prescriber and pharmacy. Note: the popular 'hCG diet' (very-low-calorie dieting combined with hCG for weight loss) is not part of hCG's approved label or supported by its evidence base, the FDA has specifically warned against marketing hCG for weight loss.
Trials and reviews
- Madhusoodanan hCG monotherapyclinical study2019
Testosterone rose ~50% on hCG alone (n=20)